Angiodynamics Inc. (ANGO)
NASDAQ · Healthcare
Angiodynamics Inc. EBITDA 2010–2025
Angiodynamics Inc. annual/quarterly ebitda history and growth rate from 2010 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Angiodynamics Inc. ebitda for the quarter ending August 31, 2025 was -4.6 M, a 26.56% decrease year-over-year.
- Angiodynamics Inc. ebitda for the twelve months ending August 31, 2025 was 25.1 M, a 498.14% increase year-over-year.
- Angiodynamics Inc. annual ebitda for 2025 was -14.2 M, a 91.41% decrease from 2024.
- Angiodynamics Inc. annual ebitda for 2024 was -164.7 M, a 711.12% increase from 2023.
- Angiodynamics Inc. annual ebitda for 2023 was -20.3 M, a 2412.98% decrease from 2022.
- Angiodynamics Inc. annual ebitda for 2022 was 878000.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Angiodynamics Inc. EBITDA — FAQ
Angiodynamics Inc. (ANGO) ebitda over the last 16 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ANGO's ebitda history?
The chart and table above show Angiodynamics Inc.'s ebitda by year and by quarter, including the growth rate.